TY - JOUR
T1 - Financial Distress in Genitourinary Cancer
T2 - Insights from CDC National Health Interview Survey
AU - Leonard, Steven
AU - Helstrom, Emma
AU - Correa, Andres
AU - Sindhani, Mohit
AU - Uzzo, Nicole
AU - Jia, Angela Y
AU - Kutikov, Alexander
AU - Uzzo, Robert
AU - Psutka, Sarah P
AU - Calaway, Adam
AU - Klaassen, Zachary
AU - Staehler, Michael
AU - Smaldone, Marc
AU - Wallis, Christopher J D
AU - Bukavina, Laura
N1 - Publisher Copyright:
© American Society of Clinical Oncology.
PY - 2024/12/1
Y1 - 2024/12/1
N2 - PURPOSEThis study leverages CDC National Health Interview Survey data to examine Financial Distress (FD) among genitourinary (GU) cancer survivors, specifically prostate cancer (PC), kidney cancer (KC), and bladder cancer (BC). It investigates the economic impacts faced by these patients, especially in relation to disparities in insurance coverage and its effects on material, psychological, and behavioral aspects of FD.METHODSWe retrospectively analyzed responses from GU cancer survivors, stratifying by cancer status and age (18-64 years, ≥65 years). Medical financial hardship was divided into three domains: material, psychological, and behavioral. Associations between cancer history, hardship, and clinical factors were assessed using generalized ordinal logistic regressions.RESULTSSignificant health care access disparities were found, particularly for mental health services, with 25% of younger BC survivors and 4.7% of younger KC survivors reporting affordability issues, in contrast to 2.7% of noncancer individuals. Dental care was also problematic, with higher avoidance rates among younger BC (27%) and KC (15%) survivors compared with the general population. Surprisingly, noncancer individuals reported more difficulty in affording prescriptions than BC survivors across both age groups. PC survivors, however, showed lower FD across all domains versus noncancer controls, indicating fewer concerns about medical bills and a lesser tendency to forgo care.CONCLUSIONThe study underscores significant gaps in the financial support system for GU cancer survivors, with urgent needs in mental and dental health care access. Policy interventions, including comprehensive insurance reforms, are imperative to alleviate the financial burdens on these individuals.
AB - PURPOSEThis study leverages CDC National Health Interview Survey data to examine Financial Distress (FD) among genitourinary (GU) cancer survivors, specifically prostate cancer (PC), kidney cancer (KC), and bladder cancer (BC). It investigates the economic impacts faced by these patients, especially in relation to disparities in insurance coverage and its effects on material, psychological, and behavioral aspects of FD.METHODSWe retrospectively analyzed responses from GU cancer survivors, stratifying by cancer status and age (18-64 years, ≥65 years). Medical financial hardship was divided into three domains: material, psychological, and behavioral. Associations between cancer history, hardship, and clinical factors were assessed using generalized ordinal logistic regressions.RESULTSSignificant health care access disparities were found, particularly for mental health services, with 25% of younger BC survivors and 4.7% of younger KC survivors reporting affordability issues, in contrast to 2.7% of noncancer individuals. Dental care was also problematic, with higher avoidance rates among younger BC (27%) and KC (15%) survivors compared with the general population. Surprisingly, noncancer individuals reported more difficulty in affording prescriptions than BC survivors across both age groups. PC survivors, however, showed lower FD across all domains versus noncancer controls, indicating fewer concerns about medical bills and a lesser tendency to forgo care.CONCLUSIONThe study underscores significant gaps in the financial support system for GU cancer survivors, with urgent needs in mental and dental health care access. Policy interventions, including comprehensive insurance reforms, are imperative to alleviate the financial burdens on these individuals.
UR - http://www.scopus.com/inward/record.url?scp=85212573564&partnerID=8YFLogxK
U2 - 10.1200/OP.23.00733
DO - 10.1200/OP.23.00733
M3 - Article
C2 - 39008789
SN - 2688-1527
VL - 20
SP - 1755
EP - 1763
JO - JCO Oncology Practice
JF - JCO Oncology Practice
IS - 12
ER -